Goldman Sachs’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$161K Buy
116,413
+88,664
+320% +$135K ﹤0.01% 6139
2025
Q4
$55.2K Sell
27,749
-466,004
-94% -$716K ﹤0.01% 6275
2025
Q3
$805K Buy
493,753
+469,647
+1,948% +$918K ﹤0.01% 5187
2025
Q2
$55K Sell
24,106
-26,305
-52% -$43.5K ﹤0.01% 5900
2025
Q1
$78.1K Sell
50,411
-75,819
-60% -$154K ﹤0.01% 5830
2024
Q4
$297K Buy
126,230
+66,218
+110% +$224K ﹤0.01% 5500
2024
Q3
$218K Sell
60,012
-18,352
-23% -$73.2K ﹤0.01% 5426
2024
Q2
$273K Sell
78,364
-137,977
-64% -$595K ﹤0.01% 5145
2024
Q1
$1.38M Buy
216,341
+84,610
+64% +$528K ﹤0.01% 4123
2023
Q4
$848K Buy
131,731
+64,910
+97% +$248K ﹤0.01% 4468
2023
Q3
$156K Sell
66,821
-26,374
-28% -$75.2K ﹤0.01% 5102
2023
Q2
$222K Buy
93,195
+71,378
+327% +$169K ﹤0.01% 5144
2023
Q1
$40.1K Buy
+21,817
New +$42.7K ﹤0.01% 5581
2022
Q4
Sell
-18,851
Closed -$40K 5976
2022
Q3
$40K Sell
18,851
-2,188
-10% -$6.48K ﹤0.01% 5825
2022
Q2
$60K Sell
21,039
-354,475
-94% -$1.08M ﹤0.01% 5990
2022
Q1
$1.57M Buy
375,514
+222,093
+145% +$934K ﹤0.01% 4443
2021
Q4
$796K Buy
153,421
+97,030
+172% +$582K ﹤0.01% 5041
2021
Q3
$369K Sell
56,391
-594,105
-91% -$3.75M ﹤0.01% 5373
2021
Q2
$4.32M Buy
650,496
+639,002
+5,559% +$3.97M ﹤0.01% 3466
2021
Q1
$66K Sell
11,494
-2,891
-20% -$21.4K ﹤0.01% 5906
2020
Q4
$129K Sell
14,385
-13,189
-48% -$141K ﹤0.01% 5240
2020
Q3
$321K Sell
27,574
-7,058
-20% -$102K ﹤0.01% 4702
2020
Q2
$555K Sell
34,632
-3,756
-10% -$41.6K ﹤0.01% 4320
2020
Q1
$230K Buy
38,388
+27,672
+258% +$256K ﹤0.01% 4642
2019
Q4
$141K Sell
10,716
-13,295
-55% -$174K ﹤0.01% 4985
2019
Q3
$298K Buy
+24,011
New +$317K ﹤0.01% 4688
2019
Q2
Sell
-8,720
Closed -$274K 5115
2019
Q1
$274K Buy
8,720
+2,026
+30% +$57.6K ﹤0.01% 4673
2018
Q4
$220K Buy
+6,694
New +$220K ﹤0.01% 4778

Other funds holding AUTL